ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0560

Outcomes of Fluoroscopic Tenckhoff Catheter Repositioning: Impact of Etiology of Malfunction and Preprocedural Catheter Position

Session Information

Category: Dialysis

  • 802 Dialysis: Home Dialysis and Peritoneal Dialysis

Authors

  • Shum, Tung sen, Division of Nephrology, Department of Medicine and Geriatrics, Princess Margaret Hospital, Hong Kong, Hong Kong
  • Cheuk, Au, Division of Nephrology, Department of Medicine and Geriatrics, Princess Margaret Hospital, Hong Kong, Hong Kong
Background

Peritoneal dialysis (PD) is the most common modality of renal replacement therapy in Hong Kong because of the "PD-First" policy. Catheter malfunction remains a significant clinical challenge. Fluoroscopic repositioning is a minimally invasive procedure for patients with catheter malfunction refractory to conservative management. This technique is safe, rapid, and allows immediate resumption of PD post-procedure. However, evidence on the impact of malfunction etiology and pre-procedural catheter position on outcomes remains limited.

Methods

This retrospective analysis included 32 consecutive PD patients from 2022 to 2024, with catheter malfunction refractory to conservative measures. Fluoroscopic repositioning using a double guidewire technique was performed. Clinical outcomes were analysed for all patients, with comparisons between omental wrap and migration groups, and evaluation of pre-procedural catheter tip position (pelvic vs. non-pelvic). Success (restored dialysate flow) was evaluated at 1 and 3 months.

Results

Mean age was 58.3 ± 16.5 years, 53.1% male. No intergroup differences in age, sex, BMI, time to malfunction (median 21[IQR8–103]d), repositioning delay (median 27[IQR15–49]d) or surgical history (p > 0.05). Overall success was 46.9% (15/32) at 1month, 43.8% (14/32) at 3months. Etiology-driven outcomes revealed significantly higher 1-month success for migration (85.7% [6/7]) versus omental wrap (33.3% [8/24]; p=0.009), with sustained durability at 3 months (71.4% [5/7] vs. 33.3% [8/24]; p=0.07). Non-pelvic catheters trended toward higher 1-month success (55.0% [11/20] vs. 33.3% [4/12]; p=0.30), with all migration cases originating from non-pelvic positions (p<0.001). 93.3% (14/15) of 1-month successes persisted at 3 months. No complications occurred.

Conclusion

Fluoroscopic Tenckhoff Catheter Repositioning is a safe procedure with 46.9% overall success at 1 month, demonstrating 93.3% durability at 3 months for initial successes. It is particularly effective for migrated catheters (85.7% 1-month success). Catheter tip located at non-pelvic region before procedure trended toward better outcomes (55.0% vs. 33.3%), aligning with migration etiology. Omental wrap’s low success (33.3%) advocates for adjunctive strategies, e.g. surgical intervention. These findings emphasize etiology-driven management to optimize technique survival.

Digital Object Identifier (DOI)